Institution identification

Institution ID

3331578

Institution full name and acronym

Peking Union Medical College Hospital

ENCePP partner

No
Institution description
No information provided.
Institution details
Experience with collecting data directly from individual patients or respondents:
No
Interest in carrying out research that is funded by pharmaceutical companies:
No

Studies conducted by the institution

A multicenter, prospective, cohort study to investigate the incidence and clinical management of CMV infection in adult patients with hematological malignancies following allogeneic hematopoietic stem cell transplantation in China
A Prospective, Non-Interventional, Post-Marketing Observational Study Evaluating the Effectiveness and Safety of Selpercatinib Capsules in Adults and Pediatric Patients with Advanced or Metastatic RET Fusion-Positive Thyroid Cancer
C16050: A national, prospective, non-interventional study of using NINLARO® in real world clinical practice
Post-Marketing Safety Study on Olumiant (Baricitinib) Use Among Moderate to Severe Active Rheumatoid Arthritis Patients in China
START: Real-world study on sequential therapy with afatinib as first-line treatment in patients with epidermal growth factor receptor (EGFR) mutation-positive advanced non-small cell lung cancer (NSCLC)